Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from TRANSFORM study
Berger, Stefan P., Sommerer, Claudia, Witzke, Oliver, Tedesco, Helio, Chadban, Steve, Mulgaonkar, Shamkant, Qazi, Yasir, de Fijter, Johan W, Oppenheimer, Federico, Cruzado, Josep M., Watarai, YoshihikLanguage:
english
Journal:
American Journal of Transplantation
DOI:
10.1111/ajt.15480
Date:
June, 2019
File:
PDF, 1.45 MB
english, 2019